Brianil
Brand names,
Brianil
Analogs
Brianil
Brand Names Mixture
Brianil
Chemical_Formula
C12H24N2O4
Brianil
RX_link
http://www.rxlist.com/cgi/generic/carisop.htm
Brianil
fda sheet
Brianil
msds (material safety sheet)
Brianil
Synthesis Reference
Berger, Ludwig, U.S. Pat. 2,937,119 (1960)
Brianil
Molecular Weight
260.33 g/mol
Brianil
Melting Point
92-93 oC
Brianil
H2O Solubility
0.3 mg/ml
Brianil
State
Solid
Brianil
LogP
1.498
Brianil
Dosage Forms
Talets
Brianil
Indication
For the relief of discomfort associated with acute, painful, musculoskeletal conditions.
Brianil
Pharmacology
Carisoprodol is used as a skeletal muscle relaxant. One of its metabolites, meprobamate, is available as an anxiolytic agent.
Brianil
Absorption
No information avaliable
Brianil
side effects and Toxicity
Symptoms of overdose include drowsiness, giddiness, nausea, indigestion, or rash. Other adverse effects attributed to therapeutic use of carisoprodol include dizziness, irritability, insomnia, diplopia, temporary loss of vision, ataxia, weakness, headache, and dysarthria. Non-CNS adverse effects include gastrointestinal complaints, tachycardia, and postural hypotension. Patients sensitive to sulfites or tartrazine may experience wheezing, allergic rashes including erythema multiforme, or anaphylaxis after using some preparations of carisoprodol which contain such additives
Brianil
Patient Information
Carisoprodol is a muscle relaxant used to relieve the pain and stiffness of muscle spasms and discomfort due to
strain and sprain. Inform your physician if you are pregnant or nursing. Do not take this medication with a monoamine
oxidase inhibitor. This medication may cause dizziness, drowsiness, or blurred vision; use caution while driving or
operating hazardous machinery. Do not take any other sedating drugs or drink alcohol while taking carisoprodol. If
dizziness occurs, avoid sudden changes in posture. Take this medication with food to avoid stomach upset. Notify your
physician if you develop trouble breathing, unexplained fever, severe weakness, vision changes, swelling, or skin
rash. Withdrawal symptoms may occur if therapy is suddenly stopped in a patient on long-term or high-dose
therapy.
Brianil
Organisms Affected
Humans and other mammals